Brett L. Ecker
Hospital of the University of Pennsylvania
7 Papers
10 Citations
Brett L. Ecker is an academic researcher from Hospital of the University of Pennsylvania. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 4, co-authored 7 publications. Previous affiliations of Brett L. Ecker include University of Pennsylvania.
Chat about Author
Papers
Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External Validation.
Timothy H. Mungroop,L. Bengt van Rijssen,David van Klaveren,F. Jasmijn Smits,Victor van Woerden,R. Linnemann,Matteo De Pastena,Sjors Klompmaker,Giovanni Marchegiani,Brett L. Ecker,Susan van Dieren,Bert A. Bonsing,Olivier R. Busch,Ronald M. van Dam,Joris I. Erdmann,Casper H.J. van Eijck,Michael F. Gerhards,Harry van Goor,Erwin van der Harst,Ignace H. J. T. de Hingh,Koert P. de Jong,Geert Kazemier,Misha D. P. Luyer,Awad Shamali,Salvatore Barbaro,T. Armstrong,Arjun Takhar,Zaed Hamady,Joost M. Klaase,Daan J. Lips,I. Quintus Molenaar,Vincent B. Nieuwenhuijs,Coen G. Rupert,Hjalmar C. van Santvoort,Joris J. Scheepers,George P. van der Schelling,Claudio Bassi,Charles M. Vollmer,Ewout W. Steyerberg,Mohammed Abu Hilal,Bas Groot Koerkamp,Marc G. Besselink +41 more
TL;DR: In this paper, the authors developed an alternative fistula risk score (a-FRS) for postoperative pancreatic fistula (POPF) after pancreatoduodenectomy, without blood loss as a predictor.
349
Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.
Brett L. Ecker,Charles M. Vollmer,Stephen W. Behrman,Valentina Allegrini,John Aversa,Chad G. Ball,Courtney E. Barrows,Adam C. Berger,Martha Navarro Cagigas,John D. Christein,Elijah Dixon,William E. Fisher,Mollie R. Freedman-Weiss,Francisco Guzman-Pruneda,Robert H. Hollis,Michael G. House,Tara S. Kent,Stacy J. Kowalsky,Giuseppe Malleo,Ronald R. Salem,Roberto Salvia,Carl Schmidt,Thomas F. Seykora,Richard Zheng,Amer H. Zureikat,Paxton V. Dickson +25 more
TL;DR: Adjuvant therapy was more frequently used in patients with poor prognostic factors but was not associated with demonstrable improvements in survival, regardless of tumor histologic subtype.
Blood Transfusion in Major Abdominal Surgery for Malignant Tumors: A Trend Analysis Using the National Surgical Quality Improvement Program.
Brett L. Ecker,Kristina D. Simmons,Salman Zaheer,Sarah-Lucy C. Poe,Edmund K. Bartlett,Jeffrey A. Drebin,Douglas L. Fraker,Rachel R. Kelz,Robert E. Roses,Giorgos C. Karakousis +9 more
TL;DR: Over 9 years of contemporary practice, a trend of less perioperative blood transfusions for oncologic abdominal surgery was observed, and whether these trends reflect changes in operative techniques, hospital cohorts, or transfusion thresholds is needed.
The impact of surgery for metastatic pancreatic neuroendocrine tumor: a contemporary evaluation matching for chromogranin a level.
Seth J. Concors,Andrew J. Sinnamon,Brett L. Ecker,David C. Metz,Charles M. Vollmer,Douglas L. Fraker,Robert E. Roses +6 more
TL;DR: CgA level is predictive of the presence of distant metastatic disease and overall survival in PNET and when matched by CgA and other predictors of treatment approach, patients with metastatic PNET undergoing surgery have improved survival.
13
Trends in practice patterns and outcomes: A decade of sarcoma care in the United States.
Yun Song,Brett L. Ecker,Rebecca Tang,Laura Maggino,Robert E. Roses,Ronald P. DeMatteo,Douglas L. Fraker,Giorgos C. Karakousis +7 more
TL;DR: OS for STS did not change at a national level over the course of a decade, although it improved at HVH, and was associated with improved rates of R0 resection at high-volume hospitals.
6